Search Results - "Weyden, Carrie"

VEXAS syndrome: A dermatological perspective by Nguyen, Jacqueline K., Routledge, David, Weyden, Carrie, Blombery, Piers, Angel, Christopher M., Johnson, Daryl, Goh, Michelle S., Lee, Adriene

“…VEXAS (Vacuoles, E1 enzyme, X‐linked, autoinflammatory and somatic mutation) syndrome is a genetically defined disorder identified in 2020, describing patients…”
Get full text

CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre by Bhabha, Friyana K., McCormack, Christopher, Campbell, Belinda A., Lade, Stephen, Buelens, Odette, Van Der Weyden, Carrie, Prince, H. Miles

“…The CD30‐postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of…”
Get full text

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma by Abeyakoon, Chathuri, van der Weyden, Carrie, Harrop, Sean, Khot, Amit, Dickinson, Michael, Yannakou, Costas K., Prince, H. Miles

“…Peripheral T-cell lymphomas (PTCLs) are distinct pathological entities with clinical advancements lagging behind their B-cell lymphoma counterpart. Frequently…”
Get full text

Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome by Photiou, Louise, van der Weyden, Carrie, McCormack, Christopher, Miles Prince, H.

“…Purpose of Review Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin lymphoma. Globally, the most common subtypes of CTCL are mycosis fungoides and…”
Get full text

Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas by Harrop, Sean, Yannakou, Costas Kleanthes, Van Der Weyden, Carrie, Prince, Henry Miles

“…The characterisation of the lymphoma epigenome has provided insight into mechanisms involved in lymphomagenesis. Multiple lymphoma subtypes demonstrate…”
Get full text

3377: Low-dose radiotherapy in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder by Ward, Jennifer, Prince, H. Miles, McCormac, Chris, Lade, Stephen, Buelens, Odette, van der Weyden, Carrie, Bhabha, Friyana, Campbell, Belinda A.

Get full text

Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look? by van der Weyden, Carrie, Harrop, Sean, Prince, Henry Miles

Get full text

288: Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes by Johnstone, Philippa, Higgins, Martin, Prince, H Miles, Lade, Stephen, Fahey, Michael, McCormack, Christopher, van der Weyden, Carrie, Bhabha, Friyana K., Buelens, Odette, Blombery, Piers, Campbell, Belinda A.

Get full text

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder by Ward, Jennifer, Prince, H. Miles, McCormack, Chris, Lade, Stephen, Buelens, Odette, van der Weyden, Carrie, Bhabha, Friyana, Campbell, Belinda A.

“…•RT achieves durable control of primary cutaneous CD4 + small/medium T-Cell LPD.•RT may be associated with lower risk of relapse than surgery.•Low dose RT…”
Get full text

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides by Elliott, Jessica, Ahlawat, Shalini, Prince, H. Miles, Kennedy, Glen, Wells, Jillian, Huang, Gillian, Collins, Jenny, Bardy, Peter, Van Der Weyden, Carrie, Ritchie, David, Khot, Amit

Get full text

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome by Gao, Crystal, McCormack, Christopher, van der Weyden, Carrie, Goh, Michelle S., Campbell, Belinda A., Twigger, Robert, Buelens, Odette, Harrison, Simon J., Khoo, Christine, Lade, Stephen, Prince, H.Miles

“…Extracorporeal photopheresis (ECP) has demonstrated therapeutic benefit in patients with Sézary syndrome (SS) and erythrodermic mycosis fungoides (e-MF). To…”
Get full text

Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies by Campbell, Belinda A, Dobos, Gabor, Haider, Zahra, Bagot, Martine, Evison, Felicity, van der Weyden, Carrie, McCormack, Chris, Ram-Wolff, Caroline, Miladi, Maryam, Prince, H Miles, Scarisbrick, Julia J

“…Traditionally, Sezary syndrome (SS) has been associated with few therapeutic options and poor prognosis, with 5-year disease-specific survival (DSS) less than…”
Get full text

Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease by Gao, Crystal, Harrop, Sean, Van Der Weyden, Carrie, McCormack, Chris, Prince, H. Miles

Get full text

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma by Watson, Leisa R., Lew, Thomas E., Fox, Lucy C., Khot, Amit, van der Weyden, Carrie

Get full text

The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma by Gao, Crystal, McCormack, Christopher J., van der Weyden, Carrie, Twigger, Robert, Buelens, Odette, Lade, Stephen, Khoo, Christine, Campbell, Belinda A., Goh, Michelle, McKelvie, Penny, Prince, H. Miles

Get full text

Brentuximab vedotin in T-cell lymphoma by Van Der Weyden, Carrie, Dickinson, Michael, Whisstock, James, Prince, H Miles

“…Brentuximab vedotin is an antibody-drug conjugate, which combines a CD30 monoclonal antibody with the microtubule-disrupting agent monomethylauristatin E. The…”
Get more information

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma by Ghione, Paola, Faruque, Promie, Mehta-Shah, Neha, Seshan, Venkatraman, Ozkaya, Neval, Bhaskar, Shakthi, Yeung, James, Spinner, Michael A., Lunning, Matthew, Inghirami, Giorgio, Moskowitz, Alison, Galasso, Natasha, Ganesan, Nivetha, van der Weyden, Carrie, Ruan, Jia, Prince, H. Miles, Trotman, Judith, Advani, Ranjana, Dogan, Ahmet, Horwitz, Steven

“…Histone deacetylase inhibitors (HDACi) are active agents for peripheral T-cell lymphoma (PTCL). Anecdotally angioimmunoblastic T-cell lymphoma (AITL) appears…”
Get full text

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era by Boussi, Leora S, Koh, Min Jung, Han, Xinyi, Peng, Luke, Koh, Min Ji, Eche, Ijeoma, Ford, Josie Germain, Singh, Shambhavi, Miranda, Eliana, Chiattone, Carlos S., Van Der Weyden, Carrie, Prince, Henry Miles, Foss, Francine M., Yoon, Sang Eun, Kim, Won-Seog, Panchoo, Girisha, Verburgh, Estelle, Cuenca Alturas, Jackielyn, Al-mansour, Mubarak, Manni, Martina, Federico, Massimo, Cabrera, Maria Elena, Casadei, Beatrice, Zinzani, Pier Luigi, Yoshida, Noriaki, Okatani, Takeshi, Merrill, Mwanasha H., Jacobsen, Eric D, O'Connor, Owen A., Marchi, Enrica, Jain, Salvia

Get full text

Impact of Therapy Sequence on Survival Outcomes Among Patients with Relapsed or Refractory Mature T and NK Cell Neoplasms: A Global Retrospective Cohort Study by Sorial, Mark N, Koh, Min Jung, Boussi, Leora, Han, Jessy Xinyi, Peng, Luke, Eche-Ugwu, Ijeoma Julie, Duan, Rui, Lei, Matthew M., Miranda, Eliana, Chiattone, Carlos, Stuver, Robert, Horwitz, Steven M., Fernandez Turizo, Maria J., McCabe, Sean, Merrill, Mwanasha Hamuza, Jacobsen, Eric, Kim, Jin Seok, Kim, Yu Ri, Cho, Jae Yong, Jain, Hasmukh, Sengar, Manju, Eipe, Thomas, Shet, Tanuja, Singh, Shambhavi, Lou, Uvette, Raghib, Hesham, Gabler, Judith, Koh, Min Ji, Van Der Weyden, Carrie, Prince, Miles, Hamouche, Ramzi, Muradashvili, Tinatin, Foss, Francine M., Gentilini, Marianna, Casadei, Beatrice, Zinzani, Pier Luigi, Okatani, Takeshi, Yoshida, Noriaki, Yoon, Sang Eun, Kim, Won Seog, Panchoo, Girisha, Mohamed, Zainab, Verburgh, Estelle, Alturas, Jackielyn Cuenca, Al Mansour, Mubarak, Ford, Josie, Manni, Martina, Federico, Massimo, O'Connor, Owen A., Cabrera, Maria Elena, Marchi, Enrica, Shen, Changyu, Shah, Devavrat, Jain, Salvia

“…Despite evolution of therapeutic strategies, there is no universal standard of care for relapsed or refractory (RR) mature T and NK-cell neoplasms (TNKL). Most…”
Get full text

Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms by Koh, Min Jung, Boussi, Leora, Han, Jessy Xinyi, Peng, Luke, Sorial, Mark N, Eche-Ugwu, Ijeoma Julie, Miranda, Eliana, Chiattone, Carlos, Stuver, Robert, Horwitz, Steven M., Fernandez Turizo, Maria J., McCabe, Sean, Merrill, Mwanasha Hamuza, Jacobsen, Eric, Kim, Jin Seok, Kim, Yu Ri, Cho, Jae Yong, Eipe, Thomas, Shet, Tanuja, Jain, Hasmukh, Sengar, Manju, Singh, Shambhavi, Gabler, Judith, Koh, Min Ji, Van Der Weyden, Carrie, Prince, Miles, Hamouche, Ramzi, Muradashvili, Tinatin, Foss, Francine M., Gentilini, Marianna, Casadei, Beatrice, Zinzani, Pier Luigi, Okatani, Takeshi, Yoshida, Noriaki, Yoon, Sang Eun, Kim, Won Seog, Panchoo, Girisha, Mohamed, Zainab, Verburgh, Estelle, Alturas, Jackielyn Cuenca, Al Mansour, Mubarak, Ford, Josie, Manni, Martina, Federico, Massimo, O'Connor, Owen A., Cabrera, Maria Elena, Shen, Changyu, Marchi, Enrica, Shah, Devavrat, Jain, Salvia

“…There is no universal approach to treat patients with relapsed and refractory (RR) mature T-cell and NK-cell neoplasms (TNKL). While participation in a…”
Get full text